FDA Warning Letter — Richard W. Foltin, Ph.D.

Case 690189 — FEI 3003469576

The FDA took a Warning Letter action against Richard W. Foltin, Ph.D. on Nov 6, 2024 (New York, NY). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.

Action Details

Facility
Richard W. Foltin, Ph.D.
Date
Nov 6, 2024
Fiscal Year
2025
Product Type
Drugs
Center
CDER
Location
New York, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.